• Explore /
  • Poster
  • / Predictive factors for effectiveness from novel androgen-receptor-axis-targeted agents in patients with metastatic prostate cancer.

Predictive factors for effectiveness from novel androgen-receptor-axis-targeted agents in patients with metastatic prostate cancer.

Abstract Video & Slides Poster

Authors

null

Koshiro Nishimoto

International Medical Center, Saitama Medical University, Hidaka, Japan

Koshiro Nishimoto , Kenichi Nakajima , Masafumi Oyama , Go Kaneko , Satoru Takahashi , Hideyasu Matsuyama , Hiroaki Shiina , Tomohiko Ichikawa , Hiroyuki Horikoshi , Katsuyoshi Hashine , Yutaka Sugiyama , Takeshi Miyao , Manabu Kamiyama , Kenichi Harada , Akito Ito , Atsushi Mizokami

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Diagnostics and Imaging

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 33)

DOI

10.1200/JCO.2022.40.6_suppl.033

Abstract #

33

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Christian Gratzke

Poster

2023 ASCO Genitourinary Cancers Symposium

Survival outcomes in metastatic castration-resistant prostate cancer in the up-front treatment era.

Survival outcomes in metastatic castration-resistant prostate cancer in the up-front treatment era.

First Author: Shunsuke Kamijo

First Author: Neal D. Shore

First Author: Daniel Joseph Khalaf